View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: UK Commercial Property REIT Ltd

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: UK Commercial Property REIT Ltd 25-Apr-2024 / 14:34 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, ...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Tyman PLC

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Tyman PLC 25-Apr-2024 / 14:33 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlo...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK PLC

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Virgin Money UK PLC 25-Apr-2024 / 14:36 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Tritax Big Box REIT PLC

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Tritax Big Box REIT PLC 25-Apr-2024 / 14:31 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the trus...

 PRESS RELEASE

NEURONES : Mise à disposition du Document d’Enregistrement Universel 2...

NEURONES : Mise à disposition du Document d’Enregistrement Universel 2023 INFORMATION PRESSE Rubrique : Document d’Enregistrement Universel 2023 Nanterre, le 25 avril 2024 Mise à disposition du Document d’Enregistrement Universel 2023 Le Document d’Enregistrement Universel 2023 a été déposé auprès de l’Autorité des Marchés Financiers (AMF). Il inclut le rapport financier annuel. Conformément à l’article 212-13 du Règlement général de l’AMF, il est tenu gratuitement à la disposition du public dans les conditions prévues par la réglementation : il est accessible dès ce jour, sous format...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Network International Holdings PL...

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Network International Holdings PLC 25-Apr-2024 / 14:26 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trus...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Redrow PLC

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Redrow PLC 25-Apr-2024 / 14:29 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settl...

 PRESS RELEASE

EQS-News: Mainz Biomed: Positive Topline-Ergebnisse einer gepoolten St...

Emittent / Herausgeber: Mainz BioMed N.V. / Schlagwort(e): Studienergebnisse Mainz Biomed: Positive Topline-Ergebnisse einer gepoolten Studie zur Evaluierung neuartiger mRNA-Biomarker und des firmeneigenen KI-Algorithmus zur Integration in die klinische FDA-Zulassungsstudie 25.04.2024 / 15:29 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Mainz Biomed: Positive Topline-Ergebnisse einer gepoolten Studie zur Evaluierung der neuartigen mRNA-Biomarker und des firmeneigenen KI-Algorithmus zur Integration in die klinische FDA-Zulassungsstu...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Spirent Communications PLC

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Spirent Communications PLC 25-Apr-2024 / 14:30 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, the t...

 PRESS RELEASE

EQS-News: Mainz Biomed Reports Positive Topline Results from Pooled St...

Issuer: Mainz BioMed N.V. / Key word(s): Study results Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next-Gen CRC Test 25.04.2024 / 15:29 CET/CEST The issuer is solely responsible for the content of this announcement. Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnost...

 PRESS RELEASE

Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corp

The Vanguard Group, Inc. ( ) Form 8.3 - The Vanguard Group, Inc.: Quanex Building Products Corp 25-Apr-2024 / 14:27 GMT/BST FORM 8.3   PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE Rule 8.3 of the Takeover Code (the “Code”)   1. KEY INFORMATION   (a) Full name of discloser: The Vanguard Group, Inc. (b) Owner or controller of interests and short positions disclosed, if different from 1(a):  The naming of nominee or vehicle companies is insufficient.  For a trust, th...

ABGSC Construct. & Real Estate Research ... (+4)
  • ABGSC Construct. & Real Estate Research
  • Fredrik Stensved
  • Markus Henriksson
  • Viktor Stenlöf
 PRESS RELEASE

CORRECTING and REPLACING Expro Group Holdings N.V. Announces First Qua...

HOUSTON--(BUSINESS WIRE)-- Sixth paragraph, last sentence of the release should read: Second quarter revenue is expected to reflect approximately 3% year-on-year growth and sequential growth of 7%, with Adjusted EBITDA Margin in an expected range of 20% to 21%, or up 200 to 300 basis points year-on-year and sequentially in both cases based on the mid-point of second quarter guidance (instead of Second quarter revenue is expected to reflect approximately 20% year-on-year growth and sequential growth of 8%, with Adjusted EBITDA Margin in an expected range of 20% to 21%, or up 200 to 300 basis po...

 PRESS RELEASE

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securi...

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) ORION CORPORATION STOCK EXCHANGE RELEASE – MAJOR SHAREHOLDER ANNOUNCEMENTS25 APRIL 2024 at 16.30 EEST         Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a disclosure under Chapter 9, Section 5 of the Securities Market Act, according to which the total number of Orion shares owned directly, indirectly and through financial instruments by BlackRock, Inc. and its funds increased on 24 April 2024 ab...

 PRESS RELEASE

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoit...

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) ORION OYJ                PÖRSSITIEDOTE – / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE         25.4.2024 KLO 16.30         Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n mukaisen ilmoituksen, jonka mukaan BlackRock, Inc.:n ja sen rahastojen suoraan, välillisesti ja rahoitusinstrumenttien kautta omistamien Orionin osakkeiden osuus on 24.4.2024 ylittänyt viisi (5) prosenttia Orion Oyj:n kaikista osakkeista. ...

 PRESS RELEASE

RGC Resources, Inc. Schedules Second Quarter 2024 Earnings Call

RGC Resources, Inc. Schedules Second Quarter 2024 Earnings Call ROANOKE, Va., April 25, 2024 (GLOBE NEWSWIRE) -- RGC Resources, Inc. (NASDAQ: RGCO) will host its quarterly conference call and webcast to review the results of its fiscal second quarter 2024 on Monday, May 6, 2024 at 9:00 a.m. eastern time. Related presentation materials will be available before the call on the Company website on the Investor & Financial Information page at . Interested parties may access the conference call by dialing toll-free 1-877-304-9269 and entering conference identification number 917621. An archi...

 PRESS RELEASE

GXO Announces Launch of Senior Notes Offering

GXO Announces Launch of Senior Notes Offering GREENWICH, Conn., April 25, 2024 (GLOBE NEWSWIRE) -- (“GXO” or the “company”) (NYSE: GXO) today announced that, subject to market and other conditions, it intends to offer one or more series of its senior notes in a registered public offering. GXO intends to use the net proceeds from the sale of the notes, together with borrowings under its previously announced term loan credit agreement entered into on March 29, 2024, to fund its pending acquisition of Wincanton plc (“Wincanton”), to fund the redemption, repayment, prepayment or satisfac...

 PRESS RELEASE

Årsstämma PolyPlank AB (publ)     

Årsstämma PolyPlank AB (publ)      PolyPlank AB (publ) har hållit årsstämma på Bolagets kontor, Färjestaden, Öland. Samtliga beslut fattades enligt styrelsens förslag fram till punkt 8c samt punkt 13 som flyttades fram före punkt 9. Punkt 9-12 ajournerades till fortsatt stämma att hållas den 13 juni 2024. Ny kallelse publiceras senast fyra veckor före den fortsatta stämman. Stämman beslutade att fastställa de i årsredovisningen intagna resultat- och balansräkningarna samt koncernresultaträkning och koncernbalansräkning.Stämman beslutade att behandla det uppkomna resultatet i enlighet med s...

 PRESS RELEASE

Mainz Biomed Reports Positive Topline Results from Pooled Study Evalua...

Mainz Biomed Reports Positive Topline Results from Pooled Study Evaluating Novel mRNA Biomarkers and Proprietary AI Algorithm for Integration into Pivotal FDA PMA Clinical Trial for Next Generation Colorectal Cancer Diagnostic Groundbreaking topline results demonstrated sensitivity for colorectal cancer of 92% with specificity of 90% and best-in-class sensitivity for advanced adenoma of 82%690 subjects analyzed including previously unexamined and reported patients from Company’s ColoFuture and eAArly DETECT studies utilizing the mRNA biomarkers, FIT test, and a proprietary AI AlgorithmThe p...

 PRESS RELEASE

Proceedings at the extraordinary general meeting on April 25, 2024

Proceedings at the extraordinary general meeting on April 25, 2024 Company announcement no 6-2024 Søborg, April 15, 2024 Proceedings at the extraordinary general meeting on April 25, 2024 An extraordinary general meeting of Konsolidator A/S took place on April 25, 2024 at Konsolidator A/S, Vandtårnsvej 83A, 2., DK-2860 Søborg, in accordance with the agenda. The board of directors elected Jakob Vig Schnack, attorney-at-law, as chairman of the meeting. The general meeting approved the only item on the agenda, which was the proposal by the board of directors to include a new author...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch